Medical Condition News

RSS

CureVac begins phase I study to assess intratumoral application of RNAdjuvant technology in patients with solid tumors

CureVac AG, a fully-integrated biotechnology company pioneering mRNA-based drugs, today announced it has initiated a Phase I study assessing the intratumoral application of its novel RNAdjuvant technology in patients with superficial solid tumors that are easily accessible for repeated intratumoral injections. RNAdjuvant is designed to amplify the scope and quality of an immune response when used alone or in combination with other immune therapies.

28 Oct 2017

ACIST Medical Systems announces debut of next generation FFR solution

ACIST Medical Systems, Inc., a Bracco Group Company, today announced the global launch of its ACIST RXi Mini System, the next generation system of its RXi Rapid Exchange FFR System. The RXi Mini System will debut at the 29th Transcatheter Cardiovascular Therapeutics scientific symposium in Denver, Colorado.

28 Oct 2017

Longevity Biotech receives award to evaluate novel drug candidate for MS in preclinical models

Longevity Biotech, Inc. has received an award from the National Multiple Sclerosis Society through Fast Forward, the Society's commercial research funding program, to evaluate LBT-3627 in preclinical models as a potential disease-modifying therapeutic agent.

28 Oct 2017

UC San Diego Health scientists help create ‘dream team’ to prevent pancreatic cancer

Scientists and physicians at Moores Cancer Center at UC San Diego Health, in partnership with colleagues at MD Anderson Cancer Center in Texas, Johns Hopkins University in Maryland and elsewhere, have been awarded a $7 million grant over four years by Stand Up to Cancer to create a "dream team" to develop new ways to prevent pancreatic cancer -- one of the nation's deadliest malignancies.

28 Oct 2017

KTU professor granted award by CNS for paradigm shift in neurology

The paper based on the study undertaken by the team of Lithuanian researchers was bestowed Paper of the Year award by The Congress of Neurological Surgeons, USA. The paper "Association of Severe TBI Patients' Outcomes with Duration of Cerebrovascular Autoregulation Impairment Events" was awarded in Neurotrauma & Critical Care section.

28 Oct 2017

ASCO's big-data, real-world health system revolutionizes future of cancer care

Future Science Group today announced the publication of an article in Future Oncology discussing the American Society of Clinical Oncology's CancerLinQ real-world, rapid learning health system.

28 Oct 2017

Chinese scientists establish synthesis of promising compound to fight against pancreatic cancer

Intriguing antitumor activity is found in a very promising class of natural compounds: cyclic depsipeptides, which have a challenging structure that makes their investigation difficult. Now, Chinese scientists have established the synthesis of a member compound, which is especially promising in killing pancreatic cancer stem cells.

28 Oct 2017

New findings offer promising druggable target to root out metastatic pancreatic cancer

Cancer of the pancreas is a deadly disease, with a median survival time of less than six months. Only one in 20 people with pancreatic cancer survives five years past the diagnosis. The reason is the cancer's insidiousness; tumor cells hide deep inside the body, betraying no symptoms until late in the disease, when the cancer has almost invariably spread to other organs.

28 Oct 2017

Clinical trial shows promising results for treatment of patients with recurrent high-grade glioma

New data from a Phase I clinical trial led by Clark Chen, M.D., Ph.D., Lyle French Chair in Neurosurgery and Head of the University of Minnesota Medical School Department of Neurosurgery shows more than a quarter of patients with recurrent high-grade glioma, a form of brain cancer, were alive more than three years after treatment.

28 Oct 2017

Breakthrough discovery could change the way of treating cholesterol

A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.

28 Oct 2017

Newly patented formulation based on nanotechnology will offer neuropathic pain relief

The company GB Sciences Inc. has obtained the exclusive global worldwide intellectual property license for this innovative solution, which is based on nanotechnology.

28 Oct 2017

Study characterizes hypertensive population with excess weight or obesity and sedentary habits

For the last seven years, researchers in the UPV/EHU's Department of Physical and Sports Education have been studying the hypertensive population with excess weight/obesity and sedentary habits. In a recent publication, this group has determined the state of health of this population through various key physical, physiological, clinical and nutritional markers and has separated them by sex and physical condition.

28 Oct 2017

Novel consortium aims to create new paradigm of cancer drug discovery

Scientists from two U.S. national laboratories, industry and academia today launched an unprecedented effort to transform the way cancer drugs are discovered by creating an open and sharable platform that integrates high-performance computing, shared biological data from public and industry sources and emerging biotechnologies to dramatically accelerate the discovery of effective cancer therapies.

27 Oct 2017

Allergists look for ways to improve ‘webside manner’

How does an allergist communicate effectively with his or her patient when they're not in the same room with the person being examined? The issue of improving "webside" manner – is one topic in a panel discussion on telemedicine during the American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

27 Oct 2017

Genome-wide molecular tests can guide treatment in recurrent glioblastoma, study shows

Several patients with recurring glioblastoma, a deadly brain cancer, survived for more than a year in a clinical trial believed to be the first to use comprehensive DNA and RNA sequencing of a patient's tumor to inform treatment for these patients in real-time.

27 Oct 2017

MUSC and SCSU join forces to address health disparities

Marvella Ford missed out on a fundamental part of childhood: having grandparents to spoil and take care of her. They all died before she was born. "That's a tremendous loss that you can never overcome. I grew up not having met or seen pictures of any of my grandparents," she said.

27 Oct 2017

Prescribed medications linked to dry mouth symptoms in older adults

For older adults, dry mouth can be a common side effect of prescribed medications. Having dry mouth means you don't have enough saliva, or spit, to keep your mouth wet. The condition can lead to problems chewing, eating, swallowing, and even talking. What's more, dry mouth puts you at higher risk for tooth decay and oral infections.

27 Oct 2017

Study: HIIT reduces brain glucose metabolism of people with type 2 diabetes, prediabetes

Researchers at the University of Turku, Finland, studied how high-intensity interval training (HIIT) alters the brain's glucose metabolism in physically inactive insulin resistant people. Only two weeks of HIIT training reduced glucose metabolism in all areas of the brain.

27 Oct 2017

Using psychotherapy to treat traumatized refugees

They are suffering from nightmares, flashbacks, depression, or anxiety disorders: refugees coming to Germany from conflict areas are frequently traumatized.

27 Oct 2017

UCLA Health Mobile Stroke Unit brings hospital to patients for saving lives and better outcomes

Roughly every 40 seconds, someone in the United States will have a stroke. Almost every four minutes, one of those people will die as a result.

27 Oct 2017

Medical Condition News

CureVac begins phase I study to assess intratumoral application of RNAdjuvant technology in patients with solid tumors

ACIST Medical Systems announces debut of next generation FFR solution

Longevity Biotech receives award to evaluate novel drug candidate for MS in preclinical models

UC San Diego Health scientists help create ‘dream team’ to prevent pancreatic cancer

KTU professor granted award by CNS for paradigm shift in neurology

ASCO's big-data, real-world health system revolutionizes future of cancer care

Chinese scientists establish synthesis of promising compound to fight against pancreatic cancer

New findings offer promising druggable target to root out metastatic pancreatic cancer

Clinical trial shows promising results for treatment of patients with recurrent high-grade glioma

Breakthrough discovery could change the way of treating cholesterol

Newly patented formulation based on nanotechnology will offer neuropathic pain relief

Study characterizes hypertensive population with excess weight or obesity and sedentary habits

Novel consortium aims to create new paradigm of cancer drug discovery

Allergists look for ways to improve ‘webside manner’

Genome-wide molecular tests can guide treatment in recurrent glioblastoma, study shows

MUSC and SCSU join forces to address health disparities

Prescribed medications linked to dry mouth symptoms in older adults

Study: HIIT reduces brain glucose metabolism of people with type 2 diabetes, prediabetes

Using psychotherapy to treat traumatized refugees

UCLA Health Mobile Stroke Unit brings hospital to patients for saving lives and better outcomes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News